Dolby Laboratories (DLB) Tops Q2 EPS by 14c

Dolby Laboratories (NYSE: DLB) reported Q2 EPS of $0.78, $0.14 better than the analyst estimate of $0.64. Revenue for the quarter came in at $301.4 million versus the consensus estimate of $300.37 million.

GUIDANCE:

Dolby Laboratories sees Q3 2018 EPS of $0.78-$0.84, versus the consensus of $0.81. Dolby Laboratories sees Q3 2018 revenue of $310-320 million, versus the consensus of $330.4 million.

Dolby Laboratories sees Q3 2018 revenue of $1.165-1.185 billion, versus the consensus of $1.18 billion.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• Inhibrx Biosciences (INBX) Reiterated at Market Perform by Citizens on INBRX-106 Ph2 Results
• Forgent Power Solutions, Inc. (FPS) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY27 Guidance